| | Public offering price(1) | | | Underwriting discount | | | Proceeds, before expenses, to us | ||||||||||
| | $ | | | % | | | $ | | | % | | | $ | | | % | |
Per 2032 Note | | | $449,334,000 | | | 99.852% | | | $2,925,000 | | | 0.650% | | | $446,409,000 | | | 99.202% |
Per 2052 Note | | | $298,038,000 | | | 99.346% | | | $2,625,000 | | | 0.875% | | | $295,413,000 | | | 98.471% |
Total | | | $747,372,000 | | | | | $5,550,000 | | | | | $741,822,000 | | |
(1) | Plus accrued interest from March 29, 2022, if settlement occurs after that date. See “Alternative Settlement Cycle”. |
J.P. Morgan | | | BofA Securities | | | Wells Fargo Securities |
Truist Securities | | | US Bancorp | | | Citizens Capital Markets | | | Citigroup |
BMO Capital Markets | | | KBC Securities USA |